TABLE 1.
Summarized clinical features of patients with PYCR2 mutations
Clinical finding | % of patients (of 14) |
---|---|
| |
Microcephaly | 100% (14/14) |
Failure to thrive | 100% (14/14) |
Ecxessive vomiting | 29% (4/14) |
Facial findings | |
Typical facies: malar hypoplasia, upturned bulbous nose, low set prominent ears | 100% (14/14) |
Triangular face | 86% (12/14) |
Neurological findings | |
Global developmental delay | 100% (14/14) |
Intellectual disability | 100% (14/14) |
Upper motor neuron signs | 100% (14/14) |
Ataxia or absent gait | 100% (14/14) |
Hyperkinetic movements | 100% (14/14) |
Muscle atrophy | 93% (13/14) |
Seizures | 57% (8/14) |
Spasticity | 57% (8/14) |
Nystagmus | 21% (3/14) |
Brain imaging findings (of 13 patients) | |
Cortical atrophy | 100% (13/13) |
Thin corpus callosum | 61% (8/13) |